Quantitative estimation of regional brain iron with magnetic resonance imaging

Parkinsonism and Related Disorders

Volumn 15, Issue SUPPL. 3, 2009, Pages

  Martin, W R Wayne ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Iron; MRI; Parkinson's disease; Substantia nigra

Indexed keywords

IRON;

ARTICLE; BASAL GANGLION; BIOCHEMISTRY; BRAIN LEVEL; DEGENERATIVE DISEASE; DISEASE COURSE; DISEASE SEVERITY; HUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PARKINSON DISEASE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SUBSTANTIA NIGRA; SYMPTOMATOLOGY;

HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; IRON; MAGNETIC RESONANCE IMAGING; PARKINSON DISEASE; SUBSTANTIA NIGRA;

EID: 71849114717     PISSN: 13538020     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1353-8020(09)70818-1     Document Type: Article

References (34)

1. Fearnley J.M., and Lees A.J. Ageing and Parkinson's disease: substantia nigra regional selectivity. Brain 114 (1991) 2283-2301
2. Youdim M.B.H., Ben-Schachar D., Yehuda S., and Riederer P. The role of iron in the basal ganglia. Adv Neurol 53 (1990) 155-162
3. Benarroch E.E. Brain iron homeostasis and neurodegenerative disease. Neurology 72 (2009) 1436-1440
4. Zecca L., Youdim M.B., Riederer P., Connor J.R., and Crichton R.R. Iron, brain ageing and neurodegenerative disorders. Nat Rev Neurosci 5 (2004) 863-873
5. Hallgren B., and Sourander P. The effect of age on the nonhaemin iron in the human brain. J Neurochem 3 (1958) 41-51
6. Zecca L., Shima T., Stroppolo A., Goj C., Battiston G.A., Gerbasi R., et al. Interaction of neuromelanin and iron in substantia nigra and other areas of human brain. Neuroscience 73 (1996) 407-415
7. Dexter D.T., Wells F.R., Lees A.J., Agid F., Agid Y., Jenner P., et al. Increased nigral iron content and alterations in other metal ions occurring in brain in Parkinson's disease. J Neurochem 52 (1989) 1830-1836
8. Sofic E., Riederer P., Heinsen H., Beckmann H., Reynolds G.P., Hebenstreit G., et al. Increased iron (III) and total iron content in post mortem substantia nigra of parkinsonian brain. J Neural Transm 74 (1988) 199-205
9. Good P.F., Olanow C.W., and Perl D.P. Neuromelanin-containing neurons of the substantia nigra accumulate iron and aluminum in Parkinson's disease: a LAMMA study. Brain Res 593 (1992) 343-364
10. Griffiths P.D., Dobson B.R., Jones G.R., and Clarke D.T. Iron in the basal ganglia in Parkinson's disease: an in vitro study using extended X-ray absorption fine structure and cryo-electron microscopy. Brain 122 (1999) 667-673
11. Schenck J.F. Magnetic resonance imaging of brain iron. J Neurol Sci 207 (2003) 99-102
12. Antinoni A., Leenders K.L., Meier D., Oertel W.H., Boesiger P., and Anliker M. T2 relaxation time in patients with Parkinson's disease. Neurology 43 (1993) 697-700
13. Vymazal J., Righini A., Brooks R.A., Canesi M., Mariani C., Leonardi M., et al. T1 and T2 in the brain of healthy subjects, patients with Parkinson disease, and patients with multiple system atrophy: relation to iron content. Radiology 211 (1999) 489-495
14. Ryvlin P., Broussolle E., Piollet H., Viallet F., Khalfallah Y., and Chazot G. Magnetic resonance imaging evience of decreased putamenal iron content in idiopathic Parkinson's disease. Arch Neurol 52 (1995) 583-588
15. Chen J.C., Hardy P.A., Kucharczyk W., Clauberg M., Joshi J.G., Vourlas A., et al. MR of human postmortem brain tissue: correlative study between T2 and assays of iron and ferritin in Parkinson and Huntington disease. AJNR Am J Neuroradiol 14 (1993) 275-281
16. Bartzokis G., Aravagiri M., Oldendorf W.H., Mintz J., and Marder S.R. Field dependent transverse relaxation rate increase may be a specific measure of tissue iron stores. Magn Reson Med 29 (1993) 459-464
17. Bartzokis G., Mintz J., Sultzer D., Marx P., Herzberg J.S., Phelan C.K., et al. In vivo MR evaluation of age-related increases in brain iron. AJNR Am J Neuroradiol 15 (1994) 1129-1138
18. Bartzokis G., Cummings J.L., Markham C.H., Marmarelis P.Z., Treciokas L.J., Tishler T.A., et al. MRI evaluation of brain iron in earlier-and later-onset Parkinson's disease and normal subjects. Magn Reson Imaging 17 (1999) 213-222
19. Ordidge R.J., Gorell J.M., Deniau J.C., Knight R.A., and Helpern J.A. Assessment of relative brain iron concentrations using T2-weighted and T2*-weighted MRI at 3 tesla. Magn Reson Med 32 (1994) 335-341
20. Ye F.Q., Martin W.R.W., and Allen P.S. Estimation of the brain iron in vivo by means of the interecho time dependence of image contrast. Magn Reson Med 36 (1996) 153-158
21. Gorell J.M., Ordidge R.J., Brown G.G., Deniau J.-C., Buderer N.M., and Helpern J.A. Increased iron-related MRI contrast in the substantia nigra in Parkinson's disease. Neurology 45 (1995) 1138-1143
22. Graham J.M., Paley M.N.J., Grunewald R.A., Hoggard N., and Griffiths P.D. Brain iron deposition in Parkinson's disease imaged using the PRIME magnetic resonance sequence. Brain 123 (2000) 2423-2431
23. Wallis L.I., Paley M.N., Graham J.M., Grünewald R.A., Wignall E.L., Joy H.M., et al. MRI assessment of basal ganglia iron deposition in Parkinson's disease. J Magn Reson Imaging 28 (2008) 1061-1067
24. Martin W.R.W., Ye F.Q., and Allen P.S. Increasing striatal iron content associated with normal aging. Mov Disord 13 (1998) 281-286
25. Ye F.Q., Allen P.S., and Martin W.R.W. Basal ganglia iron content in Parkinson's disease measured with magnetic resonance. Mov Disord 11 (1996) 243-249
26. Martin W.R.W., Roberts T.E., Ye F.Q., and Allen P.S. Increased basal ganglia iron in striatonigral degeneration: in vivo estimation with magnetic resonance. Can J Neurol Sci 25 (1998) 44-47
27. Wild J.M., Martin W.R.W., and Allen P.S. A multiple gradient echo sequence optimized for rapid, single scan mapping of R2* at high B0. Magn Reson Med 48 (2002) 867-876
28. Martin W.R.W., Wieler M., and Gee M. Midbrain iron content in early Parkinson disease: A potential biomarker of disease status. Neurology 70 (2008) 1411-1417
29. Oikawa H., Sasaki M., Tamakawa Y., Ehara S., and Tohyama K. The substantia nigra in Parkinson disease: proton density-weighted spin-echo and fast short inversion time inversion-recovery MR findings. AJNR Am J Neuroradiol 23 (2002) 1747-1756
30. Damier P., Hirsch E.C., Agid Y., and Graybiel A.M. The substantia nigra of the human brain. I. Nigrosomes and the nigral matrix, a compartmental organization based on calbindin D28K immunohistochemistry. Brain 122 (1999) 1421-1436
31. Morel A., Loup F., Magnin M., and Jeanmonod D. Neurochemical organization of the human basal ganglia: anatomofunctional territories defined by the distributions of calcium-binding proteins and SMI-32. J Comp Neurol 443 (2002) 86-103
32. Haacke E.M., Cheng N., House M.J., Liu Q., Neelavalli J., Ogg R.J., et al. Imaging iron stores in the brain using magnetic resonance imaging. Magn Reson Imag 23 (2005) 1-25
33. Haacke E.M., Mittal S., Wu Z., Neelavalli J., and Cheng Y.-C. Susceptibility-weighted imaging: technical aspects and clinical applications, Part 1. AJNR Am J Neuroradiol 30 (2009) 19-30
34. Vertinsky A.T., Coenen V.A., Lang D.J., Kolind S., Honey C.R., Li D., et al. Localization of the subthalamic nucleus: optimization with susceptibility-weighted phase MR imaging. AJNR Am J Neuroradiol 30 (2009) 1717-1724